370 related articles for article (PubMed ID: 32725800)
1. Perspective on human pluripotent stem cell-derived cardiomyocytes in heart disease modeling and repair.
Li Q; Wang J; Wu Q; Cao N; Yang HT
Stem Cells Transl Med; 2020 Oct; 9(10):1121-1128. PubMed ID: 32725800
[TBL] [Abstract][Full Text] [Related]
2. Human cardiomyocyte generation from pluripotent stem cells: A state-of-art.
Talkhabi M; Aghdami N; Baharvand H
Life Sci; 2016 Jan; 145():98-113. PubMed ID: 26682938
[TBL] [Abstract][Full Text] [Related]
3. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
[TBL] [Abstract][Full Text] [Related]
4. In vitro uses of human pluripotent stem cell-derived cardiomyocytes.
Matsa E; Denning C
J Cardiovasc Transl Res; 2012 Oct; 5(5):581-92. PubMed ID: 22639342
[TBL] [Abstract][Full Text] [Related]
5. Recent Progress Using Pluripotent Stem Cells for Cardiac Regenerative Therapy.
Ichimura H; Shiba Y
Circ J; 2017 Jun; 81(7):929-935. PubMed ID: 28603177
[TBL] [Abstract][Full Text] [Related]
6. Embryonic stem cell transplantation: promise and progress in the treatment of heart disease.
Zhang F; Pasumarthi KB
BioDrugs; 2008; 22(6):361-74. PubMed ID: 18998754
[TBL] [Abstract][Full Text] [Related]
7. Embryonic template-based generation and purification of pluripotent stem cell-derived cardiomyocytes for heart repair.
Dierickx P; Doevendans PA; Geijsen N; van Laake LW
J Cardiovasc Transl Res; 2012 Oct; 5(5):566-80. PubMed ID: 22806916
[TBL] [Abstract][Full Text] [Related]
8. Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues.
Feric NT; Radisic M
Adv Drug Deliv Rev; 2016 Jan; 96():110-34. PubMed ID: 25956564
[TBL] [Abstract][Full Text] [Related]
9. Human pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair.
Hartman ME; Dai DF; Laflamme MA
Adv Drug Deliv Rev; 2016 Jan; 96():3-17. PubMed ID: 25980938
[TBL] [Abstract][Full Text] [Related]
10. A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes.
Hemmi N; Tohyama S; Nakajima K; Kanazawa H; Suzuki T; Hattori F; Seki T; Kishino Y; Hirano A; Okada M; Tabei R; Ohno R; Fujita C; Haruna T; Yuasa S; Sano M; Fujita J; Fukuda K
Stem Cells Transl Med; 2014 Dec; 3(12):1473-83. PubMed ID: 25355733
[TBL] [Abstract][Full Text] [Related]
11. Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes.
Giacomelli E; Mummery CL; Bellin M
Cell Mol Life Sci; 2017 Oct; 74(20):3711-3739. PubMed ID: 28573431
[TBL] [Abstract][Full Text] [Related]
12. Chemical-defined and albumin-free generation of human atrial and ventricular myocytes from human pluripotent stem cells.
Pei F; Jiang J; Bai S; Cao H; Tian L; Zhao Y; Yang C; Dong H; Ma Y
Stem Cell Res; 2017 Mar; 19():94-103. PubMed ID: 28110125
[TBL] [Abstract][Full Text] [Related]
13. The march of pluripotent stem cells in cardiovascular regenerative medicine.
Abou-Saleh H; Zouein FA; El-Yazbi A; Sanoudou D; Raynaud C; Rao C; Pintus G; Dehaini H; Eid AH
Stem Cell Res Ther; 2018 Jul; 9(1):201. PubMed ID: 30053890
[TBL] [Abstract][Full Text] [Related]
14. Methods for the derivation and use of cardiomyocytes from human pluripotent stem cells.
Zhu WZ; Van Biber B; Laflamme MA
Methods Mol Biol; 2011; 767():419-31. PubMed ID: 21822893
[TBL] [Abstract][Full Text] [Related]
15. Modeling Cardiac Disease Mechanisms Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Progress, Promises and Challenges.
Parrotta EI; Lucchino V; Scaramuzzino L; Scalise S; Cuda G
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575374
[TBL] [Abstract][Full Text] [Related]
16. Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes: a Critical Step for Drug Development and Cell Therapy.
Tan SH; Ye L
J Cardiovasc Transl Res; 2018 Oct; 11(5):375-392. PubMed ID: 29557052
[TBL] [Abstract][Full Text] [Related]
17. Efficient Cardiac Differentiation of Human Amniotic Fluid-Derived Stem Cells into Induced Pluripotent Stem Cells and Their Potential Immune Privilege.
Fang YH; Wang SPH; Gao ZH; Wu SN; Chang HY; Yang PJ; Liu PY; Liu YW
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235313
[TBL] [Abstract][Full Text] [Related]
18. Progress and Challenges of Amniotic Fluid Derived Stem Cells in Therapy of Ischemic Heart Disease.
Fang YH; Wang SPH; Chang HY; Yang PJ; Liu PY; Liu YW
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374215
[TBL] [Abstract][Full Text] [Related]
19. Maturation of human pluripotent stem cell derived cardiomyocytes in vitro and in vivo.
Gomez-Garcia MJ; Quesnel E; Al-Attar R; Laskary AR; Laflamme MA
Semin Cell Dev Biol; 2021 Oct; 118():163-171. PubMed ID: 34053865
[TBL] [Abstract][Full Text] [Related]
20. Pluripotent Stem Cell-Derived Cardiomyocytes as a Platform for Cell Therapy Applications: Progress and Hurdles for Clinical Translation.
Oikonomopoulos A; Kitani T; Wu JC
Mol Ther; 2018 Jul; 26(7):1624-1634. PubMed ID: 29699941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
